Angola
Angola
Explore linked clinical trials.5 results · Page 1 of 1
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Andulo | Andulo | Angola | 1 |
| Libongue; Jamba Sede | Libongue; Jamba Sede | Angola | 1 |
| Luanda | Luanda | Angola | 4 |
| Luanda | Luanda | Angola | 1 |
| Otchinjau; Mupa | Otchinjau; Mupa | Angola | 1 |
7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 3 | 2026-08-20 | NCT05285917 | |
| LEARNER- Low dosE AspiRiN prEterm tRial (Angola) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Urogenital Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, hypertension, pregnancy-induced, inherited hemoglobinopathy, preeclampsia, pregnancy disorder, sickle cell disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-06 | NCT06417411 | |
| Realizing Effectiveness Across Continents With Hydroxyurea (REACH) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT01966731 | |
| Realizing Effectiveness Across Continents With Hydroxyurea | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 2 | 2026-04-21 | NCT06171217 | |
| Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases | Adenophorea Infections, Enoplea infectious disease, Hookworm Infections, Infections, Nematoda infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, Strongylida infectious disease, filariasis, helminthiasis, mite infestation, onchocerciasis, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, trichuriasis | Recruiting | Phase 4 | 2025-11-21 | NCT07145736 | |
| Community-based, Controlled, Open-label, Cluster-randomized Trial for the Reduction of Chronic Malnutrition in Children Under Two Years of Age, With Three Intervention Arms Grouped by Clusters, in Two Provinces in Southern Angola, Huíla and Cunene. | Child Malnutrition, Child Nutrition Disorders, Nutritional and Metabolic Diseases, nutritional disorder | Active, not recruiting | Not applicable | 2024-12-13 | NCT05571280 | |
| Study of the Role of Genetic Modifiers in Hemoglobinopathies | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, alpha thalassemia spectrum, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease, thalassemia | Recruiting | Not stated | 2024-03-20 | NCT05799118 |